RBCL (RBC Life Sciences) Total Equity: $6.92 Mil (As of Jun. 2017)


What is RBC Life Sciences Total Equity?

RBC Life Sciences RBCL +0.14% Total Equity is $6.92 Mil as of Jun. 2017.

RBC Life Sciences's total equity for the quarter that ended in Jun. 2017 was $6.92 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

RBC Life Sciences Total Equity Historical Data

* Premium members only.

The historical data trend for RBC Life Sciences's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RBC Life Sciences Total Equity Chart

RBC Life Sciences Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.52 9.01 8.43 7.88 7.13

RBC Life Sciences Quarterly Data
Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.23 7.28 7.13 7.03 6.92

RBC Life Sciences Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

RBC Life Sciences's Total Equity for the fiscal year that ended in Dec. 2016 is calculated as

Total Equity=Total Assets(Q: Dec. 2016 )-Total Liabilities(Q: Dec. 2016 )
=10.961-3.831
=7.13

RBC Life Sciences's Total Equity for the quarter that ended in Jun. 2017 is calculated as

Total Equity=Total Assets(Q: Jun. 2017 )-Total Liabilities(Q: Jun. 2017 )
=12.293-5.377
=6.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $6.92 Mil mean?
RBC Life Sciences (RBCL) has a Total Equity of $6.92 Mil as of Jun. 2017. The total amount of equity as record on a company's balance sheet. View historical data for RBC Life Sciences and its competitors.
Is RBC Life Sciences' Total Equity too high?
RBC Life Sciences' current Total Equity is $6.92 Mil.
How does RBC Life Sciences' Total Equity compare to SKVI and TISUQ?
RBC Life Sciences' Total Equity of $6.92 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Consumer Packaged Goods company?
A good Total Equity depends on the Consumer Packaged Goods industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for RBC Life Sciences and its competitors. RBC Life Sciences's current Total Equity is $6.92 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RBC Life Sciences stock overvalued right now?
RBC Life Sciences (RBCL) has a current Total Equity of $6.92 Mil. The current Total Equity is $6.92 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For RBC Life Sciences (RBCL), the current Total Equity is $6.92 Mil as of Jun. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

RBC Life Sciences Business Description

Address 2301 Crown Court, Irving, TX, USA, 75038
RBC Life Sciences Inc, through its subsidiaries, is engaged in marketing and distribution of nutritional supplements and personal care products. Its products include herbal formulas, vitamins, minerals, antioxidants, and skin, hair and body care products. It also markets its Nutritional Products in certain international markets through license arrangements. In addition to its Nutritional Products, the company also markets a line of wound care products under the MPM Medical brand name through a U.S. subsidiary.